===
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons
closely associated with them
28.03.2024 / 17:44 CET/CEST
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name


Title:

First name: Anja

Last name(s): Schorn
2. Reason for the notification a) Position / status


Person closely associated with:

Title:

First name: Anja

Last name(s): Schorn

Position: Board Member Themis Beteiligungs-AG
b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name


Dermapharm Holding SE
b) LEI


5299009F0KNZINQQQK37
4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code


Type: Share

ISIN: DE000A2GS5D8
b) Nature of the transaction


Acquisition
c) Price(s) and volume(s)


Price(s) Volume(s)

32.8918 EUR 49337.70 EUR
d) Aggregated information


Price Aggregated volume

32.8918 EUR 49337.70 EUR
e) Date of the transaction


28/03/2024; UTC+1
f) Place of the transaction


Name: XETRA

MIC: XETR

===
-----------------------------------------------------------------------------------------------------------------------

28.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      Dermapharm Holding SE 

Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

End of News EQS News Service
===
90659 28.03.2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1870269&application_name=news

END) Dow Jones Newswires

March 28, 2024 12:45 ET (16:45 GMT)